Assertio Acquired by Zydus Worldwide DMCC | Pharmacy M&A Deal
Deal Overview
Zydus Worldwide DMCC has acquired Assertio, a pharmacy business in the United States, for $23.50 per share in cash. Assertio is a pharmacy-focused company with products and capabilities relevant to pharmacy M&A and merger acquisition activity. Zydus Worldwide DMCC acquisitions in the pharmacy sector support a strategic acquisition plan to expand its footprint in U.S. pharmacy markets. The announced merger acquisition is a strategic acquisition by a strategic buyer, with deal size undisclosed, and is structured as a cash purchase at $23.50 per share.
Key Details
- Transaction
- Zydus Worldwide DMCC acquires Assertio
- Reported Value
- $23.50
Filed under
Powered by Tentt
Source pharmacy deals for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.